Uranium Royalty Corp (NASDAQ:UROY) does about 1.64M shares in volume on a normal day but saw 3213798 shares change hands in the recent trading day. The company now has a market cap of 357.21M USD. Its current market price is $2.94, marking an increase of 1.73% compared to the previous close of $2.89. The 52 week high reached by this stock is $3.76 whilst the lowest price level in 52 weeks is $1.86.
Uranium Royalty Corp (UROY) has a 20-day trading average at $2.74 and the current price is -21.81% off the 52-week high compared with 58.06% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.42 and its 200-day simple moving average is $2.54. If we look at the stock’s price movements over the week, volatility stands at 5.93%, which decreases to 5.73% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 64.60 to suggest the stock is neutral.
The consensus objective for the share price is $4.65, suggesting that the stock has a potential upside of 36.77% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 07, 2024 when B. Riley Securities initiated the stock to “Buy” and issued a price target of $3.50.
The current price level is 7.40%, 21.36%, and 15.76% away from its SMA20, SMA50, and SMA200 respectively, with the UROY price moving below the 50-day SMA on current market day. Uranium Royalty Corp (UROY) stock is down -4.55% over the week and 19.03% over the past month. Its price is 8.89% year-to-date and 8.89% over the past year.
To reach the target analysts have set, the stock logically needs to grow 36.77 percent from here.
Outstanding shares total 120.55M with insiders holding 17.20% of the shares and institutional holders owning 23.81% of the company’s common stock. The company has a return on investment of 3.88% and return on equity of 4.61%. The price to earnings ratio (P/E ratio) amounts to 44.55 while the forward price to earnings ratio is 22.18. The beta has a value of 1.51. Price to book ratio is 1.80 and price to sales ratio is 11.34.
